CLDN18 and neoplasm: Subsequently, we assessed the differences in mRNA expression levels of GYPA and CLDN18 between human hepatocellular carcinoma and adjacent non-tumor tissues, as well as between normal liver cell lines and hepatocellular carcinoma cell lines.